Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs ArcelorMittal SA (MT) Price & Performance

Axogen IncTrade
ArcelorMittal SATrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs ArcelorMittal SA — how do they compare? Axogen Inc trades at $38.83 (market cap $2.06B), while ArcelorMittal SA trades at $66.6 (market cap $50.59B). The key difference: ArcelorMittal SA is far larger — about 24.6× Axogen Inc's market cap, and ArcelorMittal SA pays a 0.9% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AXGNMT
Market Cap
$2.06B$50.59B
Sector
TechnologyBasic Materials
52-Week High
$46.19$71.65
52-Week Low
$11.28$30.39
Enterprise Value
$1.98B$59.91B
Dividend Yield
0.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.

The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.

ArcelorMittal SA

ArcelorMittal (MT) trades at $65.92, down 0.24% today, with a bullish technical outlook and strong recent earnings beats. The stock shows robust fundamentals with a P/E of 17.26 and P/S of 0.81, supported by a net income margin of 4.71% and consistent dividend payments. Recent news highlights expansion initiatives and a strategic AI collaboration with AWS, driving positive sentiment amid a 41% six-month gain (Zacks Investment Research, 2026-06-23).

Outlook remains positive with analyst consensus at 50% buy ratings, though risks include cyclical steel demand and high capital expenditure. The stock's valuation appears reasonable, but investors should monitor global economic conditions and steel pricing trends for sustained growth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About ArcelorMittal SA

ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA

Read more on MT